Drawing for THE POPULATION HEALTH MANAGEMENT COMPANY

USPTO serial 76403446

THE POPULATION HEALTH MANAGEMENT COMPANY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
WEIMER, CAROLINE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with THE POPULATION HEALTH MANAGEMENT COMPANY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cheryl A. Withycombe

CHERYL A WITHYCOMBE BAKER & MCKENZIE101 W BROADWAY 12TH FLSAN DIEGO, CA 92101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer software for medical office management, administration, record keeping, resource allocation, risk analysis, report generation, treatment analysis, case management, treatment authorization, credentialing, criteria establishment, workflow management and processing for use in the healthcare industryACTIVE—
035quality and resource management consulting services for the healthcare industry, namely, hospitals and managed care organizations; and direct marketing advertising for others namely, hospitals and managed care organizationsACTIVE—
044medical services, namely, disease management; providing health information and medical information, namely, risk management and patient screening; providing health and medical counseling; and providing computer assisted health and disease evaluation and information servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Nov 17, 2003ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 2, 2003CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 3, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 3, 2003MAILPAPER RECEIVED—
Aug 26, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance